BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 16894398)

  • 21. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
    Carroll CL; Fleischer AB
    Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical [symbol: see text] tacrolimus--a role in atopic dermatitis?
    Drug Ther Bull; 2002 Oct; 40(10):73-5. PubMed ID: 12434738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of Atopic Dermatitis and Topical Therapies.
    Mayba JN; Gooderham MJ
    J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis.
    Bekersky I; Fitzsimmons W; Tanase A; Maher RM; Hodosh E; Lawrence I
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S17-27. PubMed ID: 11145792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M; Jenerowicz D
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological profile and clinical effect of tacrolimus ointment (Protopic ointment) for atopic dermatitis].
    Hiroi J
    Nihon Yakurigaku Zasshi; 2001 May; 117(5):351-7. PubMed ID: 11411345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
    Kawashima M;
    Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR; Martin JA; Finlay AY
    Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.
    Reitamo S; Remitz A; Kyllönen H; Saarikko J
    Am J Clin Dermatol; 2002; 3(6):381-8. PubMed ID: 12113647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].
    Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D
    Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pimecrolimus: a review.
    Gupta AK; Chow M
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):493-503. PubMed ID: 12941081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long term management of childhood atopic dermatitis with calcineurin inhibitors].
    Thaçi D
    Hautarzt; 2003 May; 54(5):418-23. PubMed ID: 12719861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence.
    Iskedjian M; Piwko C; Shear NH; Langley RG; Einarson TR
    Am J Clin Dermatol; 2004; 5(4):267-79. PubMed ID: 15301573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term safety of tacrolimus ointment in atopic dermatitis.
    Remitz A; Reitamo S
    Expert Opin Drug Saf; 2009 Jul; 8(4):501-6. PubMed ID: 19435404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
    Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
    J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.